Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (110)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Clay, C. E.
Right arrow Articles by Chilton, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clay, C. E.
Right arrow Articles by Chilton, F. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 10, 1905-1911, October 1999
© 1999 Oxford University Press

Cancer Biology

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

Carl E. Clay1, Andrew M. Namen1, Gen-ichi Atsumi1, Mark C. Willingham2, Kevin P. High1, Timothy E. Kute2, Anthony J. Trimboli1, Alfred N. Fonteh1, Paul A. Dawson1 and Floyd H. Chilton1,3,4

1 Department of Internal Medicine,
2 Department of Pathology and
3 Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem,NC 27157-1054, USA

This study was undertaken to investigate the influence of the peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) agonists on the proliferation, apoptosis and tumorigenesis of breast cancer cells. PPAR{gamma} investigation has been largely restricted to adipose tissue, where it plays a key role in differentiation, but recent data reveal that PPAR{gamma} is expressed in several transformed cells. However, the function of PPAR{gamma} activation in neoplastic cells is unclear. Activation of PPAR{gamma} with the known prostanoid agonist 15-deoxy-{Delta}12,14-prostaglandin J2 (15dPGJ2) or the thiazolidinedione (TZD) agonist troglitazone (TGZ) attenuated cellular proliferation of the estrogen receptor-negative breast cancer cell line MDA-MB-231, as well as the estrogen receptor-positive breast cancer cell line MCF-7. This was marked by a decrease in total cell number and by an inhibition of cell cycle progression. Addition of 15dPGJ2 was not associated with an increase in cellular differentiation, as has been seen in other neoplastic cells, but rather induction of cellular events associated with programmed cell death, apoptosis. Video time-lapse microscopy revealed that 15dPGJ2 induced morphological changes associated with apoptosis, including cellular rounding, blebbing, the production of echinoid spikes, blistering and cell lysis. In contrast, TGZ caused only a modest induction of apoptosis. These results were verified by histochemistry using the specific DNA stain DAPI to observe nuclear condensation, a marker of apoptosis. Finally, a brief exposure of MDA-MB-231 cells to 15dPGJ2 initiated an irreversible apoptotic pathway that inhibited the growth of tumors in a nude mouse model. These findings illustrate that induction of apoptosis may be the primary biological response resulting from PPAR{gamma} activation in some breast cancer cells and further suggests a potential role for PPAR{gamma} ligands for the treatment of breast cancer.

Abbreviations: ATRA, all-trans-retinoic acid; DAPI, 4',6-diamidine-2'-phenylindole diHCl; {Delta}12-PGJ2, {Delta}12-prostaglandin J2; 15dPGJ2, 15-deoxy-{Delta}12,14-prostaglandin J2; PBS, phosphate-buffered saline; PPAR{gamma}, peroxisome proliferator-activated receptor {gamma}; PG, prostaglandin; RAR, retinoic acid receptor; RXR, retinoid X receptor; TGZ, troglitazone; TZD, thiazolidinedione.

4 To whom correspondence should be addressed Email: fchilton{at}wfubmc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. Mustafa and W. D. Kruger
Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor {gamma} Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer
Clin. Cancer Res., August 1, 2008; 14(15): 4935 - 4942.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
D Bonofiglio, H Qi, S Gabriele, S Catalano, S Aquila, M Belmonte, and S Ando
Peroxisome proliferator-activated receptor {gamma} inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner
Endocr. Relat. Cancer, June 1, 2008; 15(2): 545 - 557.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Horia and B. A. Watkins
Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells
Carcinogenesis, April 1, 2007; 28(4): 809 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, et al.
Peroxisome Proliferator-Activated Receptor-{gamma} Activates p53 Gene Promoter Binding to the Nuclear Factor-{kappa}B Sequence in Human MCF7 Breast Cancer Cells
Mol. Endocrinol., December 1, 2006; 20(12): 3083 - 3092.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. L. Lung, A. K. Leung Cheung, D. Xie, Y. Cheng, F. M. Kwong, Y. Murakami, X.-Y. Guan, J. S. Sham, D. Chua, A. I. Protopopov, et al.
TSLC1 Is a Tumor Suppressor Gene Associated with Metastasis in Nasopharyngeal Carcinoma
Cancer Res., October 1, 2006; 66(19): 9385 - 9392.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. Lei, M. Abdelrahim, and S. Safe
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
Mol. Cancer Ther., September 1, 2006; 5(9): 2324 - 2336.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Nakata, T. Yoshida, T. Shiraishi, M. Horinaka, J. Kouhara, M. Wakada, and T. Sakai
15-Deoxy-{Delta}12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPAR{gamma} and potentiates TRAIL-induced apoptosis.
Mol. Cancer Ther., July 1, 2006; 5(7): 1827 - 1835.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Kassouf, S. Chintharlapalli, M. Abdelrahim, G. Nelkin, S. Safe, and A. M. Kamat
Inhibition of Bladder Tumor Growth by 1,1-Bis(3'-Indolyl)-1-(p-Substitutedphenyl)Methanes: A New Class of Peroxisome Proliferator-Activated Receptor {gamma} Agonists
Cancer Res., January 1, 2006; 66(1): 412 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Chintharlapalli, S. Papineni, S. J. Baek, S. Liu, and S. Safe
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes Are Peroxisome Proliferator-Activated Receptor {gamma} Agonists but Decrease HCT-116 Colon Cancer Cell Survival through Receptor-Independent Activation of Early Growth Response-1 and Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1
Mol. Pharmacol., December 1, 2005; 68(6): 1782 - 1792.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. D. Yee, D. C. Young, T. J. Rosol, A. M. VanBuskirk, and S. K. Clinton
Dietary (n-3) Polyunsaturated Fatty Acids Inhibit HER-2/neu-Induced Breast Cancer in Mice Independently of the PPAR{gamma} Ligand Rosiglitazone
J. Nutr., May 1, 2005; 135(5): 983 - 988.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Piva, P. Gianferretti, A. Ciucci, R. Taulli, G. Belardo, and M. G. Santoro
15-Deoxy-{Delta}12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-{kappa}B activity and down-regulation of antiapoptotic proteins
Blood, February 15, 2005; 105(4): 1750 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Hong, I. Samudio, S. Liu, M. Abdelrahim, and S. Safe
Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Activation of p21 in Panc-28 Pancreatic Cancer Cells Involves Sp1 and Sp4 Proteins
Endocrinology, December 1, 2004; 145(12): 5774 - 5785.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-Z. Shan, K. Masuko-Hongo, S.-M. Dai, H. Nakamura, T. Kato, and K. Nishioka
A Potential Role of 15-Deoxy-{Delta}12,14-prostaglandin J2 for Induction of Human Articular Chondrocyte Apoptosis in Arthritis
J. Biol. Chem., September 3, 2004; 279(36): 37939 - 37950.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. C Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk
Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 935 - 945.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C.-H. Wang, N. Ciliberti, S.-H. Li, P. E. Szmitko, R. D. Weisel, P. W.M. Fedak, M. Al-Omran, W.-J. Cherng, R.-K. Li, W. L. Stanford, et al.
Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage: A New Paradigm in Glitazone Pleiotropy
Circulation, March 23, 2004; 109(11): 1392 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Qin, D. Morrow, J. Stewart, K. Spencer, W. Porter, R. Smith III, T. Phillips, M. Abdelrahim, I. Samudio, and S. Safe
A new class of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes
Mol. Cancer Ther., March 1, 2004; 3(3): 247 - 260.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. F. Badawi, M. B. Eldeen, Y. Liu, E. A. Ross, and M. Z. Badr
Inhibition of Rat Mammary Gland Carcinogenesis by Simultaneous Targeting of Cyclooxygenase-2 and Peroxisome Proliferator-activated Receptor {gamma}
Cancer Res., February 1, 2004; 64(3): 1181 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Qin, R. Burghardt, R. Smith, M. Wormke, J. Stewart, and S. Safe
Peroxisome Proliferator-activated Receptor {gamma} Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor {alpha} in MCF-7 Breast Cancer Cells
Cancer Res., March 1, 2003; 63(5): 958 - 964.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. E. Clay, A. Monjazeb, J. Thorburn, F. H. Chilton, and K. P. High
15-Deoxy-{Delta}12,14-prostaglandin J2-induced apoptosis does not require PPAR{gamma} in breast cancer cells
J. Lipid Res., November 1, 2002; 43(11): 1818 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Rex, M. A. Kukuruzinska, and N. W. Istfan
Inhibition of DNA replication by fish oil-treated cytoplasm is counteracted by fish oil-treated nuclear extract
Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1365 - C1375.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. L. Martelli, R. Iuliano, I. Le Pera, I. Sama', C. Monaco, S. Cammarota, T. Kroll, L. Chiariotti, M. Santoro, and A. Fusco
Inhibitory Effects of Peroxisome Proliferator-Activated Receptor {gamma} on Thyroid Carcinoma Cell Growth
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4728 - 4735.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. C. Haydon, L. Zhou, T. Feng, B. Breyer, H. Cheng, W. Jiang, A. Ishikawa, T. Peabody, A. Montag, M. A. Simon, et al.
Nuclear Receptor Agonists As Potential Differentiation Therapy Agents for Human Osteosarcoma
Clin. Cancer Res., May 1, 2002; 8(5): 1288 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Kopelovich, J. R. Fay, R. I. Glazer, and J. A. Crowell
Peroxisome Proliferator-activated Receptor Modulators As Potential Chemopreventive Agents
Mol. Cancer Ther., March 1, 2002; 1(5): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. E. Clay, G.-i. Atsumi, K. P. High, and F. H. Chilton
Early de Novo Gene Expression Is Required for 15-Deoxy-Delta 12,14-prostaglandin J2-induced Apoptosis in Breast Cancer Cells
J. Biol. Chem., December 7, 2001; 276(50): 47131 - 47135.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Berge, K. J. Tronstad, E. N. Flindt, T. H. Rasmussen, L. Madsen, K. Kristiansen, and R. K. Berge
Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways
Carcinogenesis, November 1, 2001; 22(11): 1747 - 1755.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
FASEB J, October 1, 2001; 15(12): 2057 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Thevenon, M. Guichardant, and M. Lagarde
Gas Chromatographic-Mass Spectrometric Measurement of 15-Deoxy-{{Delta}}12,14-prostaglandin J2, the Peroxisome Proliferator-activated Receptor {{gamma}} Ligand, in Urine
Clin. Chem., April 1, 2001; 47(4): 768 - 770.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. W. Han, M. E. Greene, J. Pitts, R. K. Wada, and N. Sidell
Novel Expression and Function of Peroxisome Proliferator-activated Receptor Gamma (PPAR{{gamma}}) in Human Neuroblastoma Cells
Clin. Cancer Res., January 1, 2001; 7(1): 98 - 104.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
K. Izuishi, K. Kato, T. Ogura, T. Kinoshita, and H. Esumi
Remarkable Tolerance of Tumor Cells to Nutrient Deprivation: Possible New Biochemical Target for Cancer Therapy
Cancer Res., November 1, 2000; 60(21): 6201 - 6207.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. T. Schaiff, M. G. Carlson, S. D. Smith, R. Levy, D. M. Nelson, and Y. Sadovsky
Peroxisome Proliferator-Activated Receptor-{gamma} Modulates Differentiation of Human Trophoblast in a Ligand-Specific Manner
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3874 - 3881.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. J. Trimboli, B. M. Waite, G.-i. Atsumi, A. N. Fonteh, A. M. Namen, C. E. Clay, T. E. Kute, K. P. High, M. C. Willingham, and F. H. Chilton
Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells
Cancer Res., December 1, 1999; 59(24): 6171 - 6177.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. E. Mullally, P. J. Moos, K. Edes, and F. A. Fitzpatrick
Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway
J. Biol. Chem., August 3, 2001; 276(32): 30366 - 30373.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.